首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷分子呈像/呈影劑

市場調查報告書

商品編碼

1775400

全球顯影劑市場：未來預測（2025-2030）

Global Contrast Media Market - Forecasts from 2025 to 2030

出版日期: 2025年06月26日 | 出版商:

Knowledge Sourcing Intelligence | 英文 162 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

顯影劑市場預計將從 2025 年的 63.09 億美元成長到 2030 年的 89.31 億美元，複合年成長率為 7.20%。

《顯影劑市場報告》對顯影劑產業進行了全面分析，為行業專業人士提供有關市場動態、技術進步和競爭策略的關鍵見解。本研究報告探討了顯影劑的全球格局，造影劑對於增強X光、電腦斷層掃描、MRI和超音波檢查等診斷影像程序至關重要。透過探索市場區隔、市場促進因素、市場限制和市場機會，報告為相關人員提供了可操作的資訊，幫助他們在這個不斷發展的領域中探索方向。

市場概況和範圍

顯影劑市場分析將顯影劑定義為用於醫學影像診斷，以提高特定器官、組織和血管可見度的物質。報告涵蓋顯影劑類型（碘基、鋇基、钆基、生理食鹽水食鹽水）、給藥途徑（口服、灌腸、靜脈/動脈內）、治療方式（X光、CT、MRI、超音波）、應用領域（循環系統、神經系統、胃腸道、腎臟疾病、腫瘤科）以及最終用戶（醫院、診所、診斷中心）。報告涵蓋北美、歐洲、亞太、南美、中東和非洲等主要地區，提供按地區分類的市場趨勢詳細分析。

商業和技術格局

顯影劑市場分析的商業前景部分指出了關鍵的市場促進因素，例如慢性病盛行率上升和影像技術的進步，以及市場限制因素，例如顯影劑的潛在副作用。機會包括對微創診斷日益成長的需求，以及更安全、更有效的顯影劑的技術創新。波特五力分析和產業價值鏈分析提供了對競爭壓力和供應鏈動態的洞察。技術前景部分重點介紹了將塑造市場未來的新興趨勢，例如低滲透壓顯影劑和人工智慧整合成像解決方案的發展。

競爭格局與分析

在競爭格局和分析部分，顯影劑市場分析評估了主要企業的策略、市場佔有率動態和最新發展。值得注意的進展包括拜耳公司推出的新一代碘基顯影劑，旨在降低腎毒性風險並提高 CT 影像中的病患安全性。這項創新反映了拜耳為解決監管機構對顯影劑副作用的擔憂所做的努力。同樣，通用電氣醫療集團推出了一種針對 MRI 檢查最佳化的新型钆基顯影劑，可提高穩定性並減少體內滯留。這些發展支持產業轉向以患者為中心的創新。該部分還研究了合併、收購和聯盟，包括 Guerbet 與一家領先的 AI 診斷公司的策略合作夥伴關係，以整合機器學習，從而提高顯影劑在診斷成像中的表現。市場佔有率分析和競爭儀表板清楚地顯示了 Bracco Imaging SpA、Lantheus Medical Imaging, Inc. 和 Daiichi Sankyo 等公司在這個充滿活力的市場中的定位。

市場區隔與應用

該報告根據介質類型、給藥途徑、模式、應用和最終用戶對市場進行了細分。碘基顯影劑因其在電腦斷層掃描中的廣泛應用而佔據主導地位，而钆基顯影劑在MRI應用中也發揮重要作用。心血管和神經系統疾病的增加推動了對特種顯影劑的需求，醫院和診斷中心是主要的最終用戶。按地區分類，北美憑藉其先進的醫療基礎設施引領市場，而亞太地區則因中國和印度等國家診斷成像技術的日益普及而經歷了快速成長。

策略和監管洞察

顯影劑市場研究為相關人員提供策略建議，重點關注對更安全顯影劑研發的投資以及向新興市場的擴張。研究還探討了影響產品開發和上市策略的政策和政策，例如美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 關於顯影劑安全性的嚴格指南。這些見解對於尋求滿足監管標準並把握市場機會的行業專業人士至關重要。

本報告的主要優點

深刻分析：獲得涵蓋主要地區和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
競爭格局：了解全球主要企業採取的策略策略，並了解正確策略帶來的潛在市場滲透。
市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
適用範圍廣：對於新興企業、研究機構、顧問公司、中小企業和大型企業來說，它都是實用且具有成本效益的。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024）和預測資料（2025-2030）
成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
競爭對手定位、策略和市場佔有率分析
按部門和地區（國家）分類的收益成長和預測分析
公司概況（策略、產品、財務資訊、主要趨勢等）

The Global Contrast Media Market Study provides a comprehensive analysis of the contrast media industry, offering industry experts critical insights into market dynamics, technological advancements, and competitive strategies. This study examines the global landscape of contrast media, essential for enhancing diagnostic imaging procedures such as X-rays, CT scans, MRIs, and ultrasounds. By exploring market segmentation, drivers, restraints, and opportunities, the study equips stakeholders with actionable intelligence to navigate this evolving sector.

Market Overview and Scope

The Global Contrast Media Market Study defines contrast media as substances used to improve the visibility of specific organs, tissues, or blood vessels during medical imaging. The scope encompasses various media types (iodine-based, barium-based, gadolinium, and saline), administration routes (oral, enema, intravenous/intra-arterial), modalities (X-rays, CT, MRI, ultrasound), applications (cardiovascular, neurological, gastrointestinal, nephrology disorders, and cancer), and end-users (hospitals, clinics, and diagnostic centers). The study covers key geographic regions, including North America, Europe, Asia Pacific, South America, and the Middle East and Africa, providing a granular view of regional market trends.

Business and Technological Landscape

The business landscape section of the Global Contrast Media Market Study identifies key market drivers, such as the rising prevalence of chronic diseases and advancements in imaging technologies, alongside restraints like potential side effects of contrast agents. Opportunities include the growing demand for minimally invasive diagnostics and innovations in safer, more effective contrast media. A Porter's Five Forces analysis and industry value chain analysis offer insights into competitive pressures and supply chain dynamics. The technological outlook highlights emerging trends, such as the development of low-osmolar contrast agents and AI-integrated imaging solutions, shaping the future of the market.

Competitive Environment and Analysis

In the competitive environment and analysis section, the Global Contrast Media Market Study evaluates the strategies of major players, market share dynamics, and recent developments. Notable advancements include Bayer AG's launch of a next-generation iodine-based contrast agent designed to reduce nephrotoxicity risks, enhancing patient safety in CT imaging. This innovation reflects Bayer's focus on addressing regulatory concerns about contrast media side effects. Similarly, GE HealthCare has introduced a novel gadolinium-based contrast agent optimized for MRI scans, offering improved stability and reduced retention in the body, aligning with growing demand for safer diagnostic solutions. These developments underscore the industry's shift toward patient-centric innovations. The section also explores mergers, acquisitions, and collaborations, such as Guerbet's strategic partnership with a leading AI diagnostics firm to integrate machine learning for enhanced contrast media performance in imaging. Market share analysis and a competitive dashboard provide a clear picture of how players like Bracco Imaging S.p.A., Lantheus Medical Imaging, Inc., and Daiichi Sankyo Company are positioning themselves in this dynamic market.

Market Segmentation and Applications

The study segments the market by media type, administration route, modality, application, and end-user. Iodine-based contrast media dominate due to their widespread use in CT scans, while gadolinium-based agents are critical for MRI applications. The rise in cardiovascular and neurological disorders drives demand for specialized contrast media, with hospitals and diagnostic centers as primary end-users. Regionally, North America leads due to advanced healthcare infrastructure, while Asia Pacific shows rapid growth driven by increasing diagnostic imaging adoption in countries like China and India.

Strategic and Regulatory Insights

The Global Contrast Media Market Study provides strategic recommendations for stakeholders, emphasizing investment in R&D for safer contrast agents and expansion into emerging markets. The study also examines policies and regulations, such as stringent FDA and EMA guidelines on contrast media safety, which influence product development and market entry strategies. These insights are critical for industry experts aiming to align with regulatory standards and capitalize on market opportunities.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Contrast Media Market Segmentation:

By Media Type

Iodine-based
Barium-based
Gadolinium
Saline

By Administration Route

Oral
Enema
Intravenously/Intra arterially

By Modality

X-Rays
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound

By Application

Cardiovascular disorders
Neurological disorders
Gastrointestinal disorders
Nephrology disorders
Cancer

By End-User

Hospitals and Clinics
Diagnostic Centres

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
UK
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Australia
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CONTRAST MEDIA MARKET BY MEDIA TYPE

5.1. Introduction
5.2. Iodine-based
5.3. Barium-based
5.4. Gadolinium
5.5. Saline

6. GLOBAL CONTRAST MEDIA MARKET BY ADMINISTRATION ROUTE

6.1. Introduction
6.2. Oral
6.3. Enema
6.4. Intravenously/Intraraterially

7. GLOBAL CONTRAST MEDIA MARKET BY MODALITY

7.1. Introduction
7.2. X-Rays
7.3. Computed Tomography (CT)
7.4. Magnetic Resonance Imaging (MRI)
7.5. Ultrasound

8. GLOBAL CONTRAST MEDIA MARKET BY APPLICATION

8.1. Introduction
8.2. Cardiovascular disorders
8.3. Neurological disorders
8.4. Gastrointestinal disorders
8.5. Nephrology disorders
8.6. Cancer

9.. GLOBAL CONTRAST MEDIA MARKET BY END-USER

9.1. Introduction
9.2. Hospitals and Clinics
9.3. Diagnostic Centres

10. GLOBAL CONTRAST MEDIA MARKET BY GEOGRAPHY

10.1. Introduction
10.2. North America
- 10.2.1. USA
- 10.2.2. Canada
- 10.2.3. Mexico
10.3. South America
- 10.3.1. Brazil
- 10.3.2 Argentina
- 10.3.3. Others
10.4. Europe
- 10.4.1. Germany
- 10.4.2. France
- 10.4.3. United Kingdom
- 10.4.4. Spain
- 10.4.5. Others
10.5. Middle East and Africa
- 10.5.1. Saudi Arabia
- 10.5.2. UAE
- 10.5.3. Others
10.6. Asia Pacific
- 10.6.1. China
- 10.6.2. India
- 10.6.3. Japan
- 10.6.4. South Korea
- 10.6.5. Indonesia
- 10.6.6. Thailand
- 10.6.7. Others